sex and gender in therapeutics and diagnostics for COVID-19

8 July, 2021

Dear members,

I hope that you are all doing well.

I may have reached out to you on this before- I am co-leading a thematic

group discussion on *sex and gender in therapeutics and diagnostics for

COVID-19*, with the aim to set a global research agenda in this space

<https://www.genderhealthhub.org/articles/what-why-and-how-gender-covid-1...

.

After spending a few months to obtain global input on the research needs,

issues and challenges, we are now in the research prioritization phase of

the initiative.

For this, we invite you to complete the therapeutics and diagnostics

questionnaire- a personalized link has been sent to your emails if you have

already registered for the initiative.

Please email agendasetting@unu.edu if you have not received this email, or

have not registered yet to participate in this initiative.

Visit www.ghhhbuzzboard.org for more information, and to read the five

thematic group reports.

Kind regards and many thanks,

Maryam Rumaney

HIFA profile: Maryam Rumaney is a Senior Research Assistant at the Stellenbosch Univerity in South Africa. Professional interests:Public health, HIV, TB,NCDs.

mbrumaney AT gmail.com